Asaf Bar - research works

Out of 10,829 retrieved citations, 16 studies met the inclusion criteria.

Infectious etiologies included herpetic uveitis (pooled proportion 11.40%, 95% CI 7.45-17.04%), cytomegalovirus (3.09%, 95% CI 1.01-9.06%) and tuberculosis (5.10%, 95% CI 2.58-9.83%).

Non-infectious causes, such as sarcoidosis (5.21%, 95% CI 2.78-9.55%) and HLA-B27-associated uveitis (6.05%, 95% CI 3.35-10.71%), also contributed substantially.

High heterogeneity (I 2 > 75%) was noted across most etiologies, likely reflecting variable study populations, diagnostic criteria, and geographic factors.

Intermediate uveitis has been reported to be the most common type of uveitis in association with MS.

The mechanism associating MS and uveitis is not clear, but previous data suggest a genetic predisposition may play a role.

This observation may be attributed to early immunomodulatory treatment given to those patients to treat uveitis.

Final visual acuities were 0.45 ± 0.45 and 0.8 ± 0.73 (P = 0.09), and final central macular thicknesses were 288.26 ± 55.38 and 313.12 ± 107.36 (P = 0.38) in the study and control groups, respectively.

The mean patients' age at baseline was 63.0 ± 10.0 years.

Patients underwent 3.9 ± 2.9 anti-VEGF injections for a mean of 9.1 ± 4.8 months.

BCVA gain correlated with IZ/EZ defect size reduction (r = 0.41, p = 0.02) but not with improvement in CMT (r = 0.28, p = 0.121).

Of the 31 suitable end-stage renal disease patients treated with hemodialysis who provided consent to participate, seven were unable to complete all evaluations, leaving 24 patients for analysis in the final study group.

Their mean age was 66.67±14.3 years (range: 35-88), and 62.5% were males.

Individual mean retinal layer thickness showed no significant change, including the retinal nerve fiber layer (40.9±6.8 µm to 40.1±5.2 µm, p=.412), the ganglion cell and the inner plexiform layer (68.66±8 µm to 69.03±7.6 µm, p=.639), and the photoreceptor layer (50.26±2.8 µm to 50.32±3.1 µm, p=.869).